Tissue Perfusion–Guided Vasoactive Therapies in the Critically Ill: Role of Minimally Invasive and Invasive Hemodynamic Monitoring
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Critical illness is characterized by profound alterations in tissue perfusion resulting from complex interactions between macrocirculation, microcirculation, and cellular oxygen utilization. Although macrocirculatory parameters such as mean arterial pressure and cardiac output are traditionally used to guide resuscitation, they frequently fail to reflect the adequacy of tissue oxygen delivery. Disruption of hemodynamic coherence, driven by endothelial dysfunction, microvascular thrombosis, and altered vasoregulatory balance, may lead to persistent microcirculatory impairment and cellular hypoxia despite apparent systemic stabilization. These pathophysiological mechanisms underscore the need for perfusion-oriented approaches in the management of shock. Vasoactive therapies remain central to hemodynamic support in critically ill patients, yet their effectiveness depends on appropriate selection and titration. Vasopressors primarily restore arterial pressure, while inotropes improve cardiac output and vasodilators may optimize forward flow in selected contexts. However, excessive reliance on pressure-based targets can result in overtreatment, increasing the risk of ischemia, arrhythmias, and adverse outcomes. Consequently, contemporary strategies emphasize the integration of direct tissue perfusion markers, including lactate kinetics, capillary refill time, and venous oxygen-derived variables, to individualize hemodynamic goals. Advanced hemodynamic monitoring plays a key role in this paradigm. Minimally invasive techniques allow continuous trend assessment with lower procedural risk, whereas invasive modalities provide detailed physiological data essential in complex scenarios such as cardiogenic shock or advanced heart failure. Optimal management relies on combining static and dynamic variables with bedside clinical evaluation to guide fluid and vasoactive therapy. Emerging personalized frameworks and data-driven approaches further support individualized decision-making.
Fields of Study & Subjects
Hemodynamic Monitoring and Therapy
Sepsis Diagnosis and Treatment
Trauma
Hemostasis
Coagulopathy
Resuscitation
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 28 March 2026
- Language
- EN